Skip to main content
Log in

Effect ofl-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

l-Dopa therapy has been suggested as effective in the reversal of hepatic coma both in humans and in animals. Beneficial effects have been reported also in chronic hepatic encephalopathy. There are many possible mechanisms through whichl-dopa could ameliorate this pathological state. The present study was carried out to clarify whether thel-dopa effect could be mediated through an improvement of the brain neutral amino acid patterns, since it competes for the same transport carrier at the blood-brain barrier. A first group of rats was orally administeredl-dopa (10 mg/100 g body weight daily) for 1 month following portocaval anastomosis. A second group was intraperitoneally injected (1.5 mg/100 g body weight daily) for 1 week, a month after portocaval shunt. Amino acid levels were determined in plasma and in four cerebral regions. No beneficial effects were observed clinically (in general condition, body weight, or hypertonic posture) in rats receivingl-dopa compared to controls. The large increase of tyrosine, phenylalanine, tryptophan, histidine, and glutamine that occurs in the cerebral tissue after portocaval shunt was also not affected byl-dopa administrations. In conclusion, in this experimental condition we had no clinical improvement in shunted animals receivingl-dopa. Moreover, this compound did not seem to influence the pathological increase of aromatic amino acids in the brain, which is considered to play an important role in hepatic encephalopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Abramsky, O., andGoldschmidt, Z. 1974. Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa. Surgery 75:188–193.

    PubMed  Google Scholar 

  2. Baldessarini, R. J., andFischer, J. E. 1973. Serotonin metabolism in rat brain after surgical diversion of the portal venous circulation. Nature (London), New Biol. 254:272–275.

    Google Scholar 

  3. Battistin, L., andZanchin, G. The role of amino acids in the hepatic encephalopathy. Pages 315–326,in Battistin, L., Hashim, G., andLajtha, A. (eds.), Neurochemistry and Clinical Neurology, Progress in Clinical and Biological Research, Vol. 49, Alan Liss, New York.

  4. Benson, J. V., Gordon, M. S., andPatterson, J. A. 1967. Accelerated chromatographic analysis of amino acids on physiological fluids containing glutamine and asparagine. Anal. Biochem. 18:228–232.

    Google Scholar 

  5. Biebuyck, J., Funovics, J., Dedrick, D. F., Scherer, Y. D., andFischer, J. E. 1975. Neurochemistry of hepatic coma. Alterations in putative neurotransmitter amino acids. Pages 51–60,in Williams, R., andMurray-Lyons, I. M. (eds.), Artificial Liver Support. Pitman Medical, London.

    Google Scholar 

  6. Curzon, G., Kantamaneni, B. G., Fernando J. C., Woods, M. S., andCavanagh, J. B. 1975. Effects of chronic portocaval anastomosis on brain tryptophan, tyrosine and 5-hydroxytryptamine. J. Neurochem. 24:1065–1070.

    PubMed  Google Scholar 

  7. Everett, G. M., andBorcherding, J. W. 1970.l-Dopa: Effect on concentrations of dopamine, norepinephrine and serotonin in brains of mice. Science 168:849–850.

    Google Scholar 

  8. Fischer, J. E., James, J. H., andBaldessarini, R. J. 1972. Changes in brain amines following portal flow diversion and acute hepatic coma: Effects ofl-dopa and intestinal sterilization. Surg. Forum 23:348–350.

    PubMed  Google Scholar 

  9. Fischer, J. E. 1974. False neurotransmitters and hepatic coma. Pages 53–73,in Plum, F. (ed.), Brain Dysfunction in Metabolic Disorders, Vol. 53, Raven Press, New York.

    Google Scholar 

  10. Fischer, J. E., Funovics, M., Aguirre, A., James, J. H., Keane, J. M., Wesdorp, R. I. C., Yoshimura, N., andWestman, T. 1975. The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276–290.

    PubMed  Google Scholar 

  11. Fischer, J. E., Rosen, H. M., Ebeid, A. M., Keane, J. M., andSoeters, P. B. 1976. The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91.

    PubMed  Google Scholar 

  12. Fischer, J. E., Funovics, J. M., Falcao, H. A., andWesdorp, R. I. C. 1976.l-Dopa in hepatic coma. Ann. Surg. 183:386–391.

    PubMed  Google Scholar 

  13. Goldstein, M., andFrenkel, R. 1971. Inhibition of serotonin synthesis by dopa and other catechols. Nature (London), New Biol. 233:179–180.

    Google Scholar 

  14. James, J. H., andFischer, J. E. 1975. Release of octopamine and α-methyloctopamine byl-dopa. Biochemical Pharmacol. 24:1099–1101.

    Google Scholar 

  15. James, J. H., Escourrou, J., andFischer, J. E. 1978. Blood-brain neutral amino acid transport activity is increased after portocaval anastomosis. Science 200:1395–1397.

    PubMed  Google Scholar 

  16. Lee, S. H., andFisher, B. 1961. Porto-caval shunt in the rat. Surgery 50:668–672.

    PubMed  Google Scholar 

  17. Lunzer, M., James, I. M., Weinman, J., andSherlock, S. 1974. Treatment of chronic hepatic encephalopathy with levodopa. Gut 15:555–561.

    PubMed  Google Scholar 

  18. Michel, H., Solere, M., Granier, P., Canvet, G., Bali, J. P., Pons, F. andBellet-Hermann, H. 1980. Treatment of cyrrhotic hepatic encephalopathy withl-dopa. A controlled trial. Gastroenterology 79:207–211.

    PubMed  Google Scholar 

  19. Mondino, A. 1969. A new system of automatic amino acid analysis. Part II. J. Chromatogr. 39:262–272.

    PubMed  Google Scholar 

  20. Oldendorf, W. H. 1970. Measurement of brain uptake of radiolabeled substances using a tritiated water internal standard. Brain Res. 24:372–376.

    PubMed  Google Scholar 

  21. Oldendorf, W. H. 1971. Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection. Am. J. Physiol. 221:1629–1639.

    PubMed  Google Scholar 

  22. Oldendorf, W. H., andSzabo, J. 1976. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230:94–98.

    PubMed  Google Scholar 

  23. Parkes, J. D., Sharpstone, P., andWilliams, R. 1970. Levodopa in hepatic coma. Lancet 2:1341–1343.

    PubMed  Google Scholar 

  24. Wade, D. N., Mearrick, P. T., Birkett, D. J., et al. 1974. Variability ofl-dopa absorption in man. Aust. N.Z. J. Med. 4:138–143.

    PubMed  Google Scholar 

  25. Simert, G., Nolin, A., Rosengran, E., andVang, J. 1978. Neurotransmitter changes in the rat brain after portocaval anastomosis. Eur. Surg. Res. 10:73–85.

    PubMed  Google Scholar 

  26. Zanchin, G., Rigotti, P., Dussini, N., Vassanelli, P., Battistin, L. 1979. Cerebral amino acid levels and uptake in rats after portocaval anastomosis: II Regional studies in vivo. J. Neurosci. Res. 4:301–310.

    PubMed  Google Scholar 

  27. Zanchin, G., Rigotti, P., Bettineschi, F., Dussini, N., Vassanelli, P., andBattistin, L. 1979. Effects of chronicl-dopa administration on cerebral amino acid levels in the rat after portocaval shunt. 15th Meeting of the Neuropathology Section of the Italian Neurological Society (abstract). Acta Neurol. 34:221.

    Google Scholar 

  28. Zieve, L., Doizaki, W. M., andDen, R. F. 1979. Reversal of ammonia coma in rats byl-dopa: A peripheral effect. Gut 20:28–32.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zanchin, G., Rigotti, P., Dussini, N. et al. Effect ofl-dopa treatment on cerebral amino acid levels in rats after portocaval anastomosis. Neurochem Res 6, 649–658 (1981). https://doi.org/10.1007/BF00963881

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00963881

Keywords

Navigation